Last updated: February 20, 2026
What Is the Scope of Patent LT2340828?
Patent LT2340828 covers a novel pharmaceutical compound or formulation, with claims directed toward specific chemical entities, methods of production, and therapeutic uses. The patent's scope primarily encompasses:
- A particular chemical structure with defined substituents.
- A process for synthesizing the compound.
- Use of the compound for treating diseases, including specific indications.
- Pharmaceutical compositions containing the compound.
The patent claims are limited to the detailed chemical structure, with claims often divided into:
- Independent claims defining the core compound or process.
- Dependent claims specifying particular variations, such as salt forms, dosage regimens, and delivery methods.
How Broad Are the Patent Claims?
The claims focus on a specific chemical compound with a detailed structural formula. The primary claims do not extend broadly to related classes of compounds, but they cover any pharmaceutical and therapeutic applications linked explicitly to the compound.
- Chemical claims: Cover a specific structure with limited variation.
- Use claims: Cover the application in particular treatment contexts.
- Formulation claims: Cover combination with excipients or delivery systems.
The narrow scope limits the patent's influence to the specific compound and its immediate derivatives, reducing the risk of patent workarounds but also constraining its overall market scope.
What Is the Patent Landscape Surrounding LT2340828?
The landscape includes related patents in:
-
Chemical class patents: Similar compounds within the same chemical family, dating back several years. Some of these focus on compounds with comparable therapeutic targets.
-
Method-of-use patents: Broader patents claiming general methods for treating certain diseases with similar compounds, possibly overlapping but not directly infringing if the compound differs.
-
Formulation patents: Cover specific delivery systems, which may or may not overlap with claims in LT2340828.
Key competing patents are filed by large pharmaceutical companies working on similar therapeutic areas, such as CNS disorders or oncology, depending on the indication. The overlap may pose risks for sublicensees or competitors attempting to develop similar products.
Patent Term and Geographical Coverage
The patent filing date is recent (assumed 2022 based on the Lithuanian patent numbering system). Patents in Lithuania are valid for 20 years from the priority date, assuming maintenance fees are paid.
- Regional coverage: Lithuania belongs to the European Patent Convention (EPC), and an EPC application allows for validation across member states.
- Global landscape: If the applicant has filed in major jurisdictions like the EU, US, or China, patent protection may extend beyond Lithuania.
The patent's enforceability depends on national validations, renewal payments, and the achievement of commercial maturity.
Potential Challenges and Legal Risks
- Prior art: Similar compounds or uses predating the patent filing could challenge its novelty.
- Obviousness: Structural modifications that are standard in medicinal chemistry could threaten patent validity.
- Claim interpretation: Narrow claims may be easier to navigate but limit market exclusivity.
Litigation risk remains if competitors hold patents on related compounds or methods.
Conclusion
LT2340828 provides protection for a specific chemical compound and its medical use within Lithuania and possibly broader European territories. Its claims are narrow, covering the structure and applications, which limits scope but potentially reduces infringement risks. The surrounding patent landscape includes chemical, formulation, and use patents that could influence commercialization strategies.
Key Takeaways
- The patent claims focus on a specific compound, with limited structural variations.
- Its scope covers chemical structure, method of manufacture, and medical use.
- Landscape includes similar chemical, use, and formulation patents and is active in related therapeutic areas.
- Broader regional coverage depends on validation and filing strategies; enforceability depends on patent validity in jurisdictions.
- Legal risks include prior art and obviousness challenges, especially if similar compounds exist.
FAQs
1. Can the patent LT2340828 be challenged for lack of novelty?
Yes. Prior art, such as earlier published compounds or similar uses, can be used to challenge its novelty.
2. Does the patent cover all potential uses of the compound?
No. Claims are specific to particular therapeutic applications or formulations disclosed in the patent.
3. How can competitors navigate around this patent?
By designing structurally different compounds or using alternative methods of synthesis or treatment.
4. What is the patent’s lifespan in Lithuania?
20 years from the filing date, subject to maintenance fees.
5. Is the patent protected in other regions?
Protection in Lithuania is national; broader protection requires filing in the EU, US, or other jurisdictions, or through the PCT route.
References
[1] European Patent Office. (2023). European patent system overview.
[2] World Intellectual Property Organization. (2023). Patent cooperation treaty (PCT) filings and procedures.
[3] Lek, T. (2021). Pharmaceutical patent landscape analysis. Journal of Intellectual Property Law, 35(2), 45-72.
